AB
Amplica Bio, Inc.
SEC filingBiotechnology · Wilmington, DE
Amount raised$30Ksold at filing
Total offeringNot stated
Investors in the raise1count reported to the SEC
FiledSep 11, 2026first sale Sep 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
KAUSTAV ARAS GOPINATHANExecutive Officer
KUSH DAKSHEISH MEHTAExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.